{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:46:49Z","timestamp":1793479609096,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102583"],"award-info":[{"award-number":["82102583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010306"],"award-info":[{"award-number":["2020A1515010306"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Science and Technology plan project","award":["202102020040"],"award-info":[{"award-number":["202102020040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome has been reported to be involved in the pathological process of osteoarthritis (OA) inflammation. Here, we investigated the ketogenic diet (KD), which has been previously demonstrated to inhibit NLRP3 inflammasome activation, to elucidate its protective mechanism against OA in rats.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Anterior cruciate ligament transaction (ACLT) together with partial medial meniscectomy was used to create a rat knee joint OA model. After treatment with KD or standard diet (SD) for 8 weeks, the knee specimens were obtained for testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The KD significantly increased the content of \u03b2-hydroxybutyrate (\u03b2OHB) in rats. Compared to the SD group, the KD significantly reduced the damage caused by OA in the articular cartilage and subchondral bone. The NLRP3 inflammasome and inflammatory cytokines interleukin-1 \u03b2 (IL-1\u03b2) and IL-18 were significantly increased in the SD group compared with the sham group, while their expression was significantly decreased in rats treated with the KD. In addition, MMP13 was significantly decreased in the KD group compared to that in the SD group, while COL2 was significantly increased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>KD can protect the articular cartilage and subchondral bone in a rat OA model by inhibiting NLRP3 inflammasome activation and reducing the OA inflammatory response.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-022-02802-0","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:03:50Z","timestamp":1652857430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Ketogenic diet ameliorates inflammation by inhibiting the NLRP3 inflammasome in osteoarthritis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8886-365X","authenticated-orcid":false,"given":"Ganggang","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"issue":"10","key":"2802_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"key":"2802_CR2","doi-asserted-by":"publisher","first-page":"8293921","DOI":"10.1155\/2020\/8293921","volume":"2020","author":"YY Chow","year":"2020","unstructured":"Chow YY, Chin KY. The role of inflammation in the pathogenesis of osteoarthritis. Mediat Inflamm. 2020;2020:8293921.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"2802_CR3","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1080\/21691401.2019.1647223","volume":"47","author":"N Hu","year":"2019","unstructured":"Hu N, Gong X, Yin S, Li Q, Chen H, Li Y, et al. Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis. Artif Cells, Nanomed Biotechnol. 2019;47(1):3239\u201345.","journal-title":"Artif Cells, Nanomed Biotechnol"},{"issue":"6","key":"2802_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821\u201332.","journal-title":"Cell"},{"issue":"5","key":"2802_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.joca.2018.02.901","volume":"26","author":"MJ McAllister","year":"2018","unstructured":"McAllister MJ, Chemaly M, Eakin AJ, Gibson DS, McGilligan VE. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthr Cartil. 2018;26(5):612\u20139.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"2802_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/13880209.2019.1651874","volume":"57","author":"F Cheng","year":"2019","unstructured":"Cheng F, Yan FF, Liu YP, Cong Y, Sun KF, He XM. Dexmedetomidine inhibits the NF-kappaB pathway and NLRP3 inflammasome to attenuate papain-induced osteoarthritis in rats. Pharm Biol. 2019;57(1):649\u201359.","journal-title":"Pharm Biol"},{"key":"2802_CR7","doi-asserted-by":"crossref","first-page":"4139048","DOI":"10.1155\/2021\/4139048","volume":"2021","author":"B Ni","year":"2021","unstructured":"Ni B, Pei W, Qu Y, Zhang R, Chu X, Wang Y, et al. MCC950, the NLRP3 inhibitor, protects against cartilage degradation in a mouse model of osteoarthritis. Oxidative Med Cell Longev. 2021;2021:4139048.","journal-title":"Oxidative Med Cell Longev"},{"key":"2802_CR8","doi-asserted-by":"crossref","first-page":"6116890","DOI":"10.1155\/2021\/6116890","volume":"2021","author":"H Bai","year":"2021","unstructured":"Bai H, Yuan R, Zhang Z, Liu L, Wang X, Song X, et al. Intra-articular injection of baicalein inhibits cartilage catabolism and NLRP3 inflammasome signaling in a posttraumatic OA model. Oxidative Med Cell Longev. 2021;2021:6116890.","journal-title":"Oxidative Med Cell Longev"},{"key":"2802_CR9","doi-asserted-by":"publisher","first-page":"739644","DOI":"10.3389\/fphar.2021.739644","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Liao T, Yang N, Ding L, Li X, Wu P, et al. Interventional efects of the topical of \u201cSanse Powder\u201d essential oils nanoemulsion on knee osteoarthritis in rats by targeting the ERS\/TXNIP\/NLRP3 signaling axis. Front Pharmacol. 2021;12:739644.","journal-title":"Front Pharmacol"},{"key":"2802_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fneur.2019.00585","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Shan W, Zhu F, Wu J, Wang Q. Ketone bodies in neurological diseases: focus on neuroprotection and underlying mechanisms. Front Neurol. 2019;10:585.","journal-title":"Front Neurol"},{"issue":"2","key":"2802_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11064-020-03156-2","volume":"46","author":"G Kong","year":"2021","unstructured":"Kong G, Liu J, Li R, Lin J, Huang Z, Yang Z, et al. Ketone metabolite beta-hydroxybutyrate ameliorates inflammation after spinal cord injury by inhibiting the NLRP3 inflammasome. Neurochem Res. 2021;46(2):213\u201329.","journal-title":"Neurochem Res"},{"issue":"18","key":"2802_CR12","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1089\/neu.2017.5192","volume":"34","author":"G Kong","year":"2017","unstructured":"Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X, et al. The ketone metabolite beta-hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of class I histone deacetylases. J Neurotrauma. 2017;34(18):2645\u201355.","journal-title":"J Neurotrauma"},{"issue":"1","key":"2802_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25(1):42\u201352.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2802_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cell.2019.07.048","volume":"178","author":"CW Cheng","year":"2019","unstructured":"Cheng CW, Biton M, Haber AL, Gunduz N, Eng G, Gaynor LT, et al. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet. Cell. 2019;178(5):1115\u20131131 e1115.","journal-title":"Cell"},{"issue":"6116","key":"2802_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (New York, NY). 2013;339(6116):211\u20134.","journal-title":"Science (New York, NY)"},{"key":"2802_CR16","doi-asserted-by":"crossref","unstructured":"Ding J, Xu X, Wu X, Huang Z, Kong G, Liu J, et al. Bone loss and biomechanical reduction of appendicular and axial bones under ketogenic diet in rats. Exp Ther Med. 2019.","DOI":"10.3892\/etm.2019.7241"},{"key":"2802_CR17","doi-asserted-by":"publisher","first-page":"28862","DOI":"10.1038\/srep28862","volume":"6","author":"ZH Wen","year":"2016","unstructured":"Wen ZH, Tang CC, Chang YC, Huang SY, Lin YY, Hsieh SP, et al. Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: role of TGF-beta in chondrocytes. Sci Report. 2016;6:28862.","journal-title":"Sci Report"},{"issue":"7","key":"2802_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00109-016-1418-z","volume":"94","author":"Q Ji","year":"2016","unstructured":"Ji Q, Xu X, Zhang Q, Kang L, Xu Y, Zhang K, et al. The IL-1beta\/AP-1\/miR-30a\/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis. J Mol Med. 2016;94(7):771\u201385.","journal-title":"J Mol Med"},{"issue":"2","key":"2802_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10753-016-0309-3","volume":"39","author":"C Wang","year":"2016","unstructured":"Wang C, Zeng L, Zhang T, Liu J, Wang W. Tenuigenin prevents IL-1beta-induced inflammation in human osteoarthritis chondrocytes by suppressing PI3K\/AKT\/NF-kappaB signaling pathway. Inflammation. 2016;39(2):807\u201312.","journal-title":"Inflammation"},{"key":"2802_CR20","doi-asserted-by":"crossref","unstructured":"Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols. Biomed Pharmacother. 2020;129(110452).","DOI":"10.1016\/j.biopha.2020.110452"},{"key":"2802_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.freeradbiomed.2017.02.041","volume":"106","author":"NM Khan","year":"2017","unstructured":"Khan NM, Haseeb A, Ansari MY, Devarapalli P, Haynie S, Haqqi TM. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS\/ERK\/Nrf2 signaling pathways in human osteoarthritis chondrocytes. Free Radic Biol Med. 2017;106:288\u2013301.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2802_CR22","first-page":"57","volume":"37 Suppl 120","author":"TM Griffin","year":"2019","unstructured":"Griffin TM, Scanzello CR. Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin Exp Rheumatol. 2019;37 Suppl 120(5):57\u201363.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2802_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25(2):262\u201384.","journal-title":"Cell Metab"},{"key":"2802_CR24","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","volume":"5","author":"M Rahman","year":"2014","unstructured":"Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Muller-Fielitz H, et al. The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun. 2014;5:3944.","journal-title":"Nat Commun"},{"key":"2802_CR25","doi-asserted-by":"publisher","first-page":"103959","DOI":"10.1016\/j.ebiom.2022.103959","volume":"78","author":"L Zhang","year":"2022","unstructured":"Zhang L, Shi J, Du D, Niu N, Liu S, Yang X, et al. Ketogenesis acts as an endogenous protective programme to restrain inflammatory macrophage activation during acute pancreatitis. EBioMedicine. 2022;78:103959.","journal-title":"EBioMedicine"},{"key":"2802_CR26","doi-asserted-by":"publisher","first-page":"983401","DOI":"10.1155\/2014\/983401","volume":"2014","author":"SP Fu","year":"2014","unstructured":"Fu SP, Li SN, Wang JF, Li Y, Xie SS, Xue WJ, et al. BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-kappaB activation. Mediat Inflamm. 2014;2014:983401.","journal-title":"Mediat Inflamm"},{"issue":"4","key":"2802_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00223-017-0292-1","volume":"101","author":"X Wu","year":"2017","unstructured":"Wu X, Huang Z, Wang X, Fu Z, Liu J, Huang Z, et al. Ketogenic diet compromises both cancellous and cortical bone mass in mice. Calcif Tissue Int. 2017;101(4):412\u201321.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2802_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"2802_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12951-022-01320-0","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Teng Y, Zhang C, Pan Y, Zhang Q, Zhu X, et al. The ketone body beta-hydroxybutyrate alleviates CoCrMo alloy particles induced osteolysis by regulating NLRP3 inflammasome and osteoclast differentiation. J Nanobiotechnology. 2022;20(1):120.","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"2802_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2802_CR31","first-page":"5463","volume":"17","author":"LR Zhao","year":"2018","unstructured":"Zhao LR, Xing RL, Wang PM, Zhang NS, Yin SJ, Li XC, et al. NLRP1 and NLRP3 inflammasomes mediate LPS\/ATP-induced pyroptosis in knee osteoarthritis. Mol Med Rep. 2018;17(4):5463\u20139.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2802_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13018-019-1307-6","volume":"14","author":"Y Zu","year":"2019","unstructured":"Zu Y, Mu Y, Li Q, Zhang ST, Yan HJ. Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J Orthop Surg Res. 2019;14(1):307.","journal-title":"J Orthop Surg Res"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02802-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T08:54:55Z","timestamp":1727254495000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02802-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2802"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02802-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in this study were conducted in accordance with the protocols approved by the Laboratory Animal Care and Use Committee of Nanfang Hospital, Southern Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}